CD226 and systemic sclerosis: In systemic sclerosis (SSc), EM CD8+ T cells show an upregulation of DNAM-1 which is associated with disease severity, increased cytokine production and cytotoxicity, while its expression is downregulated on NK cells in a subgroup of patients (Table 2) [17,21].